CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signaling pathway

Journal of Neuroscience Research

Volumn 91, Issue 4, 2013, Pages 545-553

  Sun, Jian Liang ^a   Xiao, Chun ^b   Lu, Bo ^c   Zhang, Juan ^d   Yuan, Xiao Zong ^b   Chen, Wei ^b   Yu, Li Na ^a   Zhang, Feng Jiang ^a   Chen, Gang ^a   Yan, Min ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Jiaxing First Hospital   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d Zhejiang Hospital of Traditional Chinese Medicine   (China)

Author keywords

CX3CL1; Extracellular signal regulated protein kinase 5; Microglia; Neuropathic pain

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HYPERALGESIA; MALE; MICROGLIA; NERVE LIGATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL NERVE;

ANIMALS; CHEMOKINE CX3CL1; HYPERALGESIA; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 7; NEURALGIA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; SPINAL NERVES;

EID: 84873702661     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23168     Document Type: Article

References (33)

1. Berton G, Fumagalli L, Laudanna C, Sorio C.1994. Beta 2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils.J Cell Biol 126:1111-1121.
2. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittmayer V, Rossi B, Schmid-Alliana A.2001. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97:2031-2037.
3. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TJ.1994. Quantitative assessment of tactile allodynia in the rat paw.J Neurosci Methods 53:55-63.
4. Corey S, Eguinoa A, Puyana-Theall K, Bolen JB, Cantley L, Mollinedo F, Jackson TR, Hawkins PT, Stephens LR.1993. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and Src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J 12:2681-2690.
5. Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY, Xia Z.2007. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway.J Cell Biol 177:253-264.
6. Gao YJ, Ji RR.2010. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126:56-68.
7. Gee CE, Griffin J, Sastre L, Miller LJ, Springer TA, Piwnica-Worms H, Roberts TM.1986. Differentiation of myeloid cells is accompanied by increased levelsof pp60c-Src protein and kinase activity. Proc Natl Acad Sci U S A 83:5131-5135.
8. Hanisch UK.2002. Microglia as a source and target of cytokines. Glia 40:140-155.
9. Hargreaves K, Dubner R, Brown F, Flores C, Joris J.1998.A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
10. Hayden MS, West AP, Ghosh S.2006.NF-kappaB and the immune response. Oncogene 25:6758-6780.
11. Ji RR, Strichartz G.2004. Cell signaling and the genesis of neuropathic pain. Sci STKE 252:reE14.
12. Kim SH, Chung JM.1992. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
13. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N.2005. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 22:1977-1986.
14. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ.2004. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 19:3375-3381.
15. Lindia JA, McGowan E, Jochnowitz N, Abbadie C.2005. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.J Pain 6:434-438.
16. Miller RJ, Jung H, Bhangoo SK, White FA.2009. Cytokine and chemokine regulation of sensory neuron function. Hdbk Exp Pharmacol 194:417-449.
17. Milligan ED, Watkins LR.2009. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23-36.
18. Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, Foster AC, Naeve GS, Maier SF, Watkins LR.2004. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20:2294-2302.
19. Obata K, Katsura H, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Noguchi K.2007. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain.J Neurochem 102:1569-1584.
20. Okubo M, Yamanaka H, Kobayashi K, Noguchi K.2010. Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain. Glia 58:599-610.
21. Owolabi SA, Saab CY.2006. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett 580:4306-4310.
22. Raghavendra V, Tanga F, DeLeo JA.2003. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy.J Pharmacol Exp Ther 306:624-630.
23. Scapoli L, Ramos-Nino ME, Martinelli M, Mossman BT.2004. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23:805-813.
24. Staniland AA, Clark AK, Wodarski R, Sasso O, Maione F, D'Acquisto F, Malcangio M.2010. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.J Neurochem 114:1143-1157.
25. Sweitzer SM, Schubert P, DeLeo JA.2001. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.J Pharmacol Exp Ther 297:1210-1217.
26. Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC.2004. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20:1150-1160.
27. Wang RM, Zhang QG, Zhang GY.2004. Activation of ERK5 is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated calcium channel via Src involving oxidative stress after cerebral ischemia in rat hippocampus. Neurosci Lett 357:13-16.
28. Wang X, Tournier C.2006. Regulation of cellular functions by the ERK5 signaling pathway. Cell Signal 18:753-760.
29. Woolf CJ, Salter MW.2000. Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.
30. Xiao C, Zhang L, Cheng QP, Zhang LC.2008. The activation of extracellular signal-regulated protein kinase 5 in spinal cord and dorsal root ganglia contributes to inflammatory pain. Brain Res 1215:76-86.
31. Yaksh TL, Rudy TA.1976. Chronic catheterization of the subarachnoid space. Physiol Behav 7:1032-1036.
32. Zhou M, Lublin DM, Link DC, Brown EJ.1995. Distinct tyrosine kinase activation and triton X-100 insolubility upon FcgRIIIB ligation in human polymorphonuclear leukocytes.J Biol Chem 270:13553-13560.
33. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR.2007. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21:642-651.